Dear Shareholders and Investors,A major project for 2025 is to renew and grow our fleet. We plan to buy two or three ...

In a letter to shareholders, CEO Herbjorn Hansson said, “A major project for 2025 is to renew and grow our fleet. We plan to buy two or three ...

Morgan Stanley raised the firm’s price target on Nordic Semiconductor (NDCVF) to NOK 90 from NOK 85 and keeps an Underweight rating on the ...

While we have spent the last few years focusing heavily on global markets, in 2025, we are giving greater attention to Europe,” says Justas Morkunas, Chief Commercial Officer for B2B at Nord Security.

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

U.S.-based EV maker Tesla (TSLA) has faced a setback in Sweden and Norway as CEO Elon Musk’s local reputation in the region ...

The goal of QR-02 is to treat and reduce dysplasia levels, potentially offering a curative solution for oral leukoplakia, an outcome that would mark a significant breakthrough in oral medicine. By ...

Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...

Gallagher Re’s international division chairman James Vickers is to retire from the business at the end of May this year, ...